FDA批准的个新药————————————————————————————————作者:————————————————————————————————日期: (Glucarpidase)——BTGInternationalInc. (IngenolMebutate)——LEOPharmaAS (Vismodegib)——GenentechInc.(RocheGroup) (Ivacaftor)——VertexPharmaceuticalsInc. (Tafluprost)——Merck&. (Lucinactant)——DiscoveryLaboratoriesInc. (Peginesatide)——AffymaxInc. (FlorbetapirF18)——AvidRadiopharmaceuticals(EliLilly) (Avanafil)——VIVUSInc. (Taliglucerasealfa)——ProtalixBioTherapeuticsInc.&PfizerInc. (Pertuzumab)——GenentechInc.(RocheGroup) (Lorcaserin)——ArenaPharmaceuticals (Mirabegron)——AstellasPharmaUS,Inc. (Prepopik)——FerringPharmaceuticals (Carfilzomib)——OnyxPharmaceuticals (AclidiniumBromide)——ForestPharmaceuticals (ziv-Aflibercept)——Sanofi-Aventis (Stribild)——GileadSciences (Tbo-filgrastim)——SicorBiotechUAB(TevaCorporation) (Linaclotide)——IronwoodPharmaceuticalsInc.&ForestPharmaceuticalsInc. (Enzalutamide)——AstellasPharmaUS,Inc.&Medivation,Inc. (Bosutinib)——PfizerInc. (Teriflunomide)——SanofiAventis (CholineC11)——MayoClinicPETRadiochemistryFacility (Regorafenib)——BayerHealthCarePharmaceuticals (Ocriplasmin)——ThromboGenicsInc. (Perampanel)——EisaiInc. (inate)——TevaPharmaceuticals. (Tofacitinib)——PfizerInc. (Cabozantinib)——Exelixis (Ponatinib)——ARIADPharmaceuticals (Raxibacumab)——HumanGenomeSciences(GlaxoSmithKline) (Pasireotide)——NovartisPharmaSteinAG (Teduglutide)——NPSPharmaceuticals (Lomitapide)——AegerionPharmaceuticalsInc. (Apixaban)——Bristol-MyersSquibb&PfizerInc. (Bedaquiline)——JanssenTherapeutics(Johnson&Johnson) (Crofelemer)——SalixPharmaceuticals&NapoPharmaceuticals,Inc. (Glucarpidase)——。甲氨蝶呤为抗叶酸类抗肿瘤药,主要通过对二氢叶酸还原酶的抑制而阻止肿瘤细胞的生长和增殖
FDA批准的个新药 来自淘豆网m.daumloan.com转载请标明出处.